Research output per year
Research output per year
Search results
-
2021
cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries
Qi, M., Nayar, U., Ludwig, L. S., Wagle, N. & Rheinbay, E., Dec 2021, In: BMC Bioinformatics. 22, 1, 611.Research output: Contribution to journal › Article › peer-review
Open Access -
2020
Acquired FGFR and FGF alterations confer resistance to Estrogen Receptor (ER) targeted therapy in ERþ metastatic breast cancer
Mao, P., Cohen, O., Kowalski, K. J., Kusiel, J. G., Buendia-Buendia, J. E., Cuoco, M. S., Exman, P., Wander, S. A., Waks, A. G., Nayar, U., Chung, J., Freeman, S., Rozenblatt-Rosen, O., Miller, V. A., Piccioni, F., Root, D. E., Regev, A., Winer, E. P., Lin, N. U. & Wagle, N., Nov 15 2020, In: Clinical Cancer Research. 26, 22, p. 5974-5989 16 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases
Persky, N. S., Hernandez, D., Do Carmo, M., Brenan, L., Cohen, O., Kitajima, S., Nayar, U., Walker, A., Pantel, S., Lee, Y., Cordova, J., Sathappa, M., Zhu, C., Hayes, T. K., Ram, P., Pancholi, P., Mikkelsen, T. S., Barbie, D. A., Yang, X., Haq, R., & 3 others, Jan 1 2020, In: Nature Structural and Molecular Biology. 27, 1, p. 92-104 13 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor–positive metastatic breast cancer
Wander, S. A., Cohen, O., Gong, X., Johnson, G. N., Buendia-Buendia, J. E., Lloyd, M. R., Kim, D., Luo, F., Mao, P., Helvie, K., Kowalski, K. J., Nayar, U., Waks, A. G., Parsons, S. H., Martinez, R., Litchfield, L. M., Ye, X. S., Yu, C., Jansen, V. M., Stille, J. R., & 12 others, 2020, In: Cancer discovery. 10, 8, p. 1174-1193 20 p.Research output: Contribution to journal › Article › peer-review
22 Scopus citations -
2019
Acquired HER2 mutations in ER + metastatic breast cancer confer resistance to estrogen receptor–directed therapies
Nayar, U., Cohen, O., Kapstad, C., Cuoco, M. S., Waks, A. G., Wander, S. A., Painter, C., Freeman, S., Persky, N. S., Marini, L., Helvie, K., Oliver, N., Rozenblatt-Rosen, O., Ma, C. X., Regev, A., Winer, E. P., Lin, N. U. & Wagle, N., Feb 1 2019, In: Nature genetics. 51, 2, p. 207-216 10 p.Research output: Contribution to journal › Letter › peer-review
55 Scopus citations -
2017
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies
Nayar, U., Sadek, J., Reichel, J., Hernandez-Hopkins, D., Akar, G., Barelli, P. J., Sahai, M. A., Zhou, H., Totonchy, J., Jayabalan, D., Niesvizky, R., Guasparri, I., Hassane, D., Liu, Y., Sei, S., Shoemaker, R. H., Warren, J. D., Elemento, O., Kaye, K. M. & Cesarman, E., Jun 1 2017, In: Journal of Clinical Investigation. 127, 6, p. 2066-2080 15 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
2013
Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies
Nayar, U., Lu, P., Goldstein, R. L., Vider, J., Ballon, G., Rodina, A., Taldone, T., Erdjument-Bromage, H., Chomet, M., Blasberg, R., Melnick, A., Cerchietti, L., Chiosis, G., Wang, Y. L. & Cesarman, E., 2013, In: Blood. 122, 16, p. 2837-2847 11 p.Research output: Contribution to journal › Article › peer-review
Open Access50 Scopus citations